Featured
A Roundtable on Complications in Retinal Surgery
Surgeons discuss cases where the unexpected happened and how they managed them.
By Christina Y. Weng, MD, MBA, Lejla Vajzovic, MD, FASRS, Yoshihiro Yonekawa, MD, et al.
Tips for Managing Complicated Macular Holes
Mastering several techniques enables retina specialists to offer tailored approaches to patients.
By Dilraj S. Grewal, MD, FASRS
Combined Phacovitrectomy Surgery
Update on outcomes, innovations, and interspecialty collaborations.
By Hiram J. Jimenez Davila, MD, Victor M. Villegas, MD, Timothy G. Murray, MD, MBA, FACS
Management of Dislocated Intraocular Lenses
Many options exist that retina surgeons can use for repositioning and exchange.
By Maria H. Berrocal, MD, Luis A. Acaba-Berrocal, MD
Departments
Upfront: Same Retinal Physician, New Platform
As media evolves, so do our trusted sources of clinical information.
By Peter K. Kaiser, MD
Coding: Understanding the New +G2211 Code
Retina specialists must be careful when billing this new HCPCS code, as it will only be appropriate in rare cases.
By Brandy H. Sperry, COMT, COE, CPC, CPMA
Uveitis Corner: A 2024 Update on Clinical Trials in Uveitis
This review will focus on the phase 2-4 uveitis trials listed as “active” on clinicaltrials.gov, with the majority assessing noninfectious uveitis.
By Sruthi Arepalli, MD
New Product Applications: C. Light Launches First-of-Its-Kind Retitrack
Monitoring eye movement can provide new insights.
By Karen Appold, contributing writer
Clinical Trial Update July/August 2024
Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.
News
FDA Clears AI Device for Portable Diabetic Retinopathy Screening
AEYE Health announced that it has received the first FDA clearance for a fully autonomous AI system that diagnoses referable diabetic retinopathy (DR) from retinal images captured by a handheld camera.
By Rochelle Nataloni, contributing writer
Foundation Fighting Blindness Partners With PreventionGenetics
The My Retina Tracker Genetic Testing Program aims to advance research focused on inherited retinal diseases.
By Rochelle Nataloni, contributing writer
First Patient Dosed in Inflammasome GA Clinical Trial
The trial will study kamuvudine-8 for geographic atrophy due to age-related macular degeneration.
By Rochelle Nataloni, contributing writer
Ocugen Meets Dosing Milestone in Stargardt Disease Trial
Dosing is complete in a phase 1/2 trial for a modifier gene therapy for Stargardt disease.
By Rochelle Nataloni, contributing writer
Blue-light IOLs Reduce Progression of Macular Atrophy, But Not Incidence
A recent study published in the American Journal of Ophthalmology evaluated the impact of blue-light intraocular lenses.
By Rochelle Nataloni, contributing writer
CRISPR Trial Demonstrates Potential Advances for Inherited Blindness
Results showed 11 of 14 patients had improvement in vision and quality-of-life measures.
By Rochelle Nataloni, contributing writer
Ocular Telehealth Program Enables Remote Retina Disease Screening
Visionix and 20/20NOW announced the launch of their collaborative Ocular Telehealth Program.
By Rochelle Nataloni, contributing writer
New Algorithm to Identify Patients With UME Presented at ARVO
The algorithm identified 3 times more patients with active UME compared to only using ICD-10 codes.
By Rochelle Nataloni, contributing writer
Eye2Gene and Heidelberg Announce Collaborative Partnership
The collaboration aims to provide eye care professionals with insights into genetic diagnosis of inherited retinal disease.
By Rochelle Nataloni, contributing writer
PULSAR Analysis of Aflibercept in nAMD Presented at ARVO
Findings suggest that aflibercept 8 mg with extended dosing intervals is as effective as the more frequent 2 mg dosing.
By Rochelle Nataloni, contributing writer
Study Highlights Demographic Disparities in Diabetic Retinopathy Care
The study assessed associations between neighborhood-level social determinants of health and risk for lapses in diabetic retinopathy care.
By Rochelle Nataloni, contributing writer
Initial UK Faricimab Real-world Outcomes Presented at ARVO
Results suggest a rapid extension in faricimab treatment intervals after the initial doses.
By Rochelle Nataloni, contributing writer
Study: Time to First Anti-VEGF Injection in Treatment-naïve Wet AMD Patients
Patients who wait to start treatment might have worse outcomes.
By Rochelle Nataloni, contributing writer
New ARCHER ANX007 in GA Treatment Findings Presented at ARVO
David Boyer, MD, presented results highlighting a neuroprotective mechanism.
By Rochelle Nataloni, contributing writer
Understanding Risk Factors for Posterior Capsular Rupture
Austrian study finds that history of intravitreal injections does not increase the likelihood of PCR during cataract surgery.
Alcon’s Unity VCS and CS Receive FDA 510(k) Clearance
The company's new systems are the first solutions to be introduced from Alcon’s Unity portfolio of surgical equipment.
ANI Pharmaceuticals to Acquire Alimera Sciences
The $381 million deal expands ANI’s presence in ophthalmology.
FDA Grants De Novo Status to Notal’s Patient-operated OCT Device
Retina specialists will be able to prescribe the Scanly Home OCT device for home monitoring.